Seeking Alpha

Shares of Vivus (VVUS) continue their restless ways, up 6.3% premarket, after analysts continue...

Shares of Vivus (VVUS) continue their restless ways, up 6.3% premarket, after analysts continue to tag the company as an acquisition target following the firm's well-publicized FDA panel recommendation for its weight-loss drug.
Comments (2)
  • MexCom
    , contributor
    Comments (3050) | Send Message
     
    Take over price to be above $40.
    29 Feb 2012, 10:26 AM Reply Like
  • phemale60
    , contributor
    Comments (2776) | Send Message
     
    You betcha!
    29 Feb 2012, 02:19 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|